As reported, 4 days post implant of the bard/davol perfix plug, the patient experienced redness, swelling, pain and a "mass"; was treated with anti-infection medications and recovered.
Based on the information provided, no conclusion can be made.
Review of manufacturing records confirms product was manufactured to specification, with no indication of a manufacturing related cause for the event reported.
To date, this is the only reported complaint for this manufacturing lot of (b)(4) units released for distribution in september, 2020.
In regards to the infection, the warnings section of the ifu states "if an infection develops, treat the infection aggressively.
Consideration should be given regarding the need to remove the mesh.
An unresolved infection may require removal of the device.
" should additional information be provided a supplemental mdr will be submitted.
Not returned - remains implanted.
|
Per nmpa ((b)(6) fda): as reported, the patient underwent left indirect inguinal hernia repair under aseptic conditions with implant of a bard/davol perfix plug on (b)(6) 2021.
It was reported that the patient experienced post-operative complications including local redness, swelling, pain and "mass" on (b)(6) 2021.
As reported, the patient was treated with anti-infection medications, local hot compress and the patient recovered on (b)(6) 2021.
|